国: 台湾
言語: 中国語
ソース: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
CETRORELIX ACETATE
台灣默克股份有限公司 台北市內湖區堤頂大道2段89號6樓 (23526610)
H01CC02
凍晶注射劑
CETRORELIX ACETATE (9200042810) (0.26-0.27mg)MG
小瓶裝;;附等支數1公撮注射針筒裝溶劑
製 劑
限由醫師使用
Abbott Biologicals B.V. VEERWEG 12, 8121 AA OLST, THE NETHERLANDS NL
cetrorelix
預防接受卵巢強效刺激排卵治療的患者,早發性的排出不成熟的卵。
有效日期: 2026/08/01; 英文品名: CETROTIDE 0.25MG
2001-08-01
Based on EU SmPC verion 03/10/2019 and CCDSv4 (Cetrotide) CETROTIDE 0.25 MG powder and solvent for solution for injection 1. NAME OF THE MEDICINAL PRODUCT CETROTIDE 0.25 MG POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 0.25 mg cetrorelix (as acetate). After reconstitution with the solvent provided, each ml of the solution contains 0.25 mg cetrorelix. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Powder and solvent for solution for injection. Appearance of the powder: white lyophilisate Appearance of the solvent: clear and colourless solution The pH of the reconstituted solution is 4.0 – 6.0 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Cetrotide should only be prescribed by a specialist experienced in this field. Posology The first administration of Cetrotide should be performed under the supervision of a physician and under conditions where treatment of possible allergic/pseudo-allergic reactions (including life-threatening anaphylaxis) is immediately available. The following injections may be self-administered as long as the patient is made aware of the signs and symptoms that may indicate hypersensitivity, the consequences of such a reaction and the need for immediate medical intervention. The contents of 1 vial (0.25 mg cetrorelix) are to be administered once daily, at 24 h intervals, either in the morning or in the evening. Following the first administration, it is advised that the patient be kept under medical supervision for 30 minutes to ensure there is no allergic/pseudo-allergic reaction to the injection. _ _ _Elderly _ There is no relevant use of Cetrotide in the geriatric population. _ _ _Paediatric population _ There is no relevant use of Cetrotide in the paediatric population. Method of administration Cetroti 完全なドキュメントを読む